Related Experiment Videos
Reconstitution of human factor VIII from isolated subunits
1Department of Medicine, University of Rochester School of Medicine and Dentistry, New York 14642.
Archives of Biochemistry and Biophysics
|May 1, 1988
Summary
Human factor VII activity requires both heavy and light chains, which can be reconstituted with metal ions. Von Willebrand factor significantly enhances this factor VII reconstitution process.
Area of Science:
- Biochemistry
- Hematology
Background:
- Human factor VII is a critical clotting protein composed of heavy and light chains.
- Understanding the subunit interactions is key to comprehending factor VII function and potential therapeutic strategies.
Purpose of the Study:
- To investigate the functional roles of human factor VII heavy and light chains.
- To determine the conditions required for factor VII activity reconstitution.
- To explore the influence of von Willebrand factor on factor VII reconstitution.
Main Methods:
- Fractionation of human factor VII heterodimers into heavy and light chains using a specific monoclonal antibody.
- Reconstitution assays in the presence of divalent metal ions (Mn2+, Ca2+) and varying ionic strengths.
- Analysis of subunit recombination using monoclonal antibody immunosorbant and specific activity measurements.
Main Results:
- Neither isolated heavy nor light chains exhibited factor VII activity.
- Activity was restored upon recombining the subunits, dependent on metal ions and ionic strength, indicating the importance of hydrophobic and electrostatic interactions.
- Optimal reconstitution occurred at a 1:1 molar ratio of light to heavy chain, achieving maximum specific activity.
- Von Willebrand factor increased the rate of factor VII reconstitution up to 5-fold in an ionic strength- and dose-dependent manner.
Conclusions:
- Human factor VII activity is dependent on the proper association of its heavy and light chains.
- Metal ions and specific ionic conditions are crucial for factor VII subunit recombination and function.
- Von Willebrand factor acts as a significant enhancer for factor VII reconstitution, suggesting a role in modulating clotting factor activity.